Emily and Tom Whitehead, Dean Kamen to Deliver Keynote Addresses at DIA 2024 Global Annual Meeting
DIA , a global organization of life sciences professionals, will feature the patient perspectives of Emily and Tom Whitehead and insights from inventor Dean Kamen during keynote addresses at the DIA 2024 Global Annual Meeting , to be held June 16-20 in San Diego.
- DIA , a global organization of life sciences professionals, will feature the patient perspectives of Emily and Tom Whitehead and insights from inventor Dean Kamen during keynote addresses at the DIA 2024 Global Annual Meeting , to be held June 16-20 in San Diego.
- Emily Whitehead was diagnosed with acute lymphoblastic leukemia (ALL) in May 2010, when she was 5 years old.
- Children have an 85% to 90% chance of being cured of this disease, but existing treatment options did not work for Emily.
- Kamen is an entrepreneur and advocate for science and technology who holds more than 1,000 U.S. and foreign patents.